When the time is right, Nasrat is ready to Rock & Roll.
Drug C below
Elite's Unique second generation IR ADF is 90% cheaper to produce compared to ADFs containing Naltrexone. It can also be used with CNS stimulants to make them abuse deterrent. The holy grail of IR ADFs trials resume in 2020 Making others obsolete.
Hammer locking the IR ADF market in 2021
Patent Pending
Quote Nasrat:
“I am extremely excited about this formulation because it is also a platform that applies to all the IRs and its about 10% of the cost. So we're extremely excited about this, but it's still early, in the next few months once Dr. Smith files a patent and we do a few more trials, we’ll update everyone more about it. “
AI
